We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Freeze-Dried Heart Valves Hold Promise in Replacement Procedures

By HospiMedica International staff writers
Posted on 29 Feb 2012
Tissue-engineered replacement heart valves can be made from the residual biological scaffold left after cellular material has been removed, and can be freeze-dried and stored for later use.

Researchers at Leibniz Universität Hannover (Germany) and Hannover Medical School dissected porcine hearts to investigate the structure, biomechanical properties, and elasticity of freeze-dried decellularized porcine pulmonary heart valves. More...
To do so, the tissues were first decellularized and then separated in three groups; without lyoprotectant; with 5% sucrose; and with a mixture of 2.5% sucrose and 2.5% hydroxyl ethylene starch (HES). They then underwent freeze-drying.

The results showed that freeze-drying in the absence of lyoprotectants resulted in the largest pore sizes, but caused an overall more disintegrated appearance of the histological architecture of the porcine valves, especially between the fibrosa and the ventricularis layers. The elastic modulus of freeze-dried tissue without protectants was reduced, and resembled that of decellularized tissue. Freeze-dried tissue with lyoprotectants had a looser network of collagen and elastic fibers with bigger pore sizes, and showed pores of intermediate sizes between the decellularized tissue and the unprotected freeze-dried samples.

In all, tissue freeze-dried with sucrose looked more intact and displayed less porosity than tissue freeze-dried using a sucrose/HES mixture, whereas no significant differences in biomechanical properties were observed. The researchers concluded that the increased pore size of freeze-dried tissue could be advantageous for the adherence of circulating stem cells. The biomechanical tests show that decellularization significantly affected the biomechanical properties and elastic modulus of the tissues, but that the biomechanical properties of the valves freeze-dried with sucrose more closely resembled those of native tissue. The study was published online ahead of print on January 7, 2012, in Tissue Engineering, Part C: Methods.

“Mechanical valve prostheses bear a high risk of thromboembolic events and bleeding after implantation,” wrote lead author PhD candidate Shangping Wang, MSc, of the Leibniz Institute of Multiphase Processes. “Tissue engineering, the regeneration of tissue with the aid of support structures, may provide alternative solutions for mechanical valves.”

Freeze-drying is a technique where water is removed from frozen material under reduced pressure, first by sublimation of the freezable water fraction (primary drying), followed by desorption of the unfrozen water (secondary drying).Freeze-drying, however, is damaging to biomolecules and can cause a collapse of the extracellular matrix (ECM) structure and denaturation of sensitive proteins, and thus it requires protective additives. The rationale for using a mixture of sucrose and HES is that sucrose forms hydrogen bonds with tissue proteins in the dried state, whereas HES is used to elevate the glass transition temperature during the freeze-drying procedure.

Related Links:

Leibniz Universität Hannover
Hannover Medical School



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.